Global Rosuvastatin Market 2023-2030

    In Stock

    Coming Soon




    A drug called rosuvastatin is used to decrease high blood triglyceride and cholesterol levels. It is a member of the statin medication family that lowers cholesterol by blocking a liver enzyme involved in the production of cholesterol.


    Rosuvastatin aids in lowering levels of LDL (bad cholesterol) and raising levels of HDL (good cholesterol) by reducing the quantity of cholesterol generated.


    People with high cholesterol who are at risk for cardiovascular illness, such as a heart attack or stroke, are frequently administered rosuvastatin. It is typically advised together with a healthy diet and exercise routine and is taken orally in the form of a pill.


    As with many medicines, rosuvastatin has the potential to cause side effects, such as muscle soreness, liver damage, and an elevated risk of diabetes.


    Before beginning any new drug, including rosuvastatin, it is vital to explore the potential risks and benefits with a healthcare professional. 




    infographic: Rosuvastatin Market, Rosuvastatin Market Size, Rosuvastatin Market Trends, Rosuvastatin Market Forecast, Rosuvastatin Market Risks, Rosuvastatin Market Report, Rosuvastatin Market Share


    Global rosuvastatin market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    For the treatment of elevated low-density lipoprotein cholesterol (LDL-C) in adult patients with primary non-familial hyperlipidemia and in adult patients with homozygous familial hypercholesterolemia, Althera Pharmaceuticals received FDA approval for Roszet, a combination of rosuvastatin and ezetimibe.


    Additionally, Watson Pharmaceuticals has been given permission to sell generic rosuvastatin calcium in a variety of strengths.


    A drug called rosuvastatin can help prevent cardiovascular disease by lowering harmful cholesterol levels. In addition to launching Roszet in 25 European nations, Althera is preparing to do so in additional countries throughout the globe.


    In individuals with primary non-familial hyperlipidemia to lower low-density lipoprotein cholesterol (LDL-C), and in people with homozygous familial hypercholesterolemia (HoFH) to lower LDL-C, Roszet is recommended as an adjunct to diet.


    The rosuvastatin/ezetimibe dosages for Roszet come in strengths of 5 mg/10 mg, 10 mg/10 mg, 20 mg/10 mg, and 40 mg/10 mg. Roszet has the ability to lower LDL cholesterol by up to 72% at a dose of 40 mg/10 mg and by 64% at a dose of 10 mg/10mg.



    • AstraZeneca
    • Teva Pharmaceuticals
    • Actavis Pharma
    • Glenmark Pharmaceuticals
    • Torrent Pharmaceuticals
    • Cadila Healthcare
    • Sun Pharmaceutical Industries
    • Cipla Limited
    • Lupin Limited
    • Dr. Reddy’s Laboratories



    1. How many rosuvastatin are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global rosuvastatin and key vendor selection criteria
    3. Where is the rosuvastatin manufactured? What is the average margin per unit?
    4. Market share of Global rosuvastatin market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global rosuvastatin in-house
    6. key predictions for next 5 years in Global rosuvastatin market
    7. Average B-2-B rosuvastatin market price in all segments
    8. Latest trends in rosuvastatin market, by every market segment
    9. The market size (both volume and value) of the rosuvastatin market in 2023-2030 and every year in between?
    10. Production breakup of rosuvastatin market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop